Evaluating a Clinical Ethics Committee (CEC) Implementation Process

计划入组 20 人 · 首次发布于 2022 年 7 月 20 日

Sickle Cell Disease: A Retrospective Chart Review

计划入组 261 人 · 首次发布于 2011 年 9 月 27 日

Secondary Care Colorectal Cancer Pathway Review

计划入组 25,000 人 · 首次发布于 2026 年 2 月 24 日

GPCR modulators

USP30 inhibitors (Mission Therapeutics)

ACLY inhibitors (metabolic disease/cancer)

Surgical Review Corporation

United States

Institutional Review Board

United States

OSAKA CENTER FOR CANCER AND CARDIOVASCULAR DISEASE PREVENTION

Japan

Lunsumio Shows Durable 3-Year Remission in Follicular Lymphoma, Setting New Benchmark for Bispecific Antibodies

FDA Advisory Committee to Review Rare Disease Treatment Amid Efficacy Concerns

FDA Advisory Committee to Review Elamipretide for Barth Syndrome